Lessons learned from investigator‐initiated clinical trials for localized pancreatic cancer-Reference-Cited by-同舟云学术

Lessons learned from investigator‐initiated clinical trials for localized pancreatic cancer

Published:2021-12-13 Issue:1 Volume:125 Page:69-74
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Tsai Susan¹^ORCID,Evans Douglas B.¹

Affiliation:

1. LaBahn Pancreatic Cancer Program Medical College of Wisconsin Milwaukee Wisconsin USA

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26756

Reference10 articles.

1. Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor;Jordan VC;Eur J Cancer,1975

2. World Health Organization. World Health Organization Model List of Essential Medicines.2021. C:/Users/stsai/Downloads/WHO-MHP-HPS-EML-2021.02-eng.pdf

3. Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma;Groot VP;Ann Surg,2017

4. Management of Patients with Pancreatic Adenocarcinoma: National Trends in Patient Selection, Operative Management, and Use of Adjuvant Therapy

5. Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of factors that act as barriers in conducting academic trials – An investigator’s perception;Perspectives in Clinical Research;2023-12-19

2. The Development of Investigator-Initiated Clinical Trials in Surgical Oncology;Surgical Oncology Clinics of North America;2023-01